About this trial

The goal of this clinical trial is to determine whether the Endotracheal Tube Position Anomaly Alerting System (ETPAAS) effectively reduces the duration of endotracheal tube malposition in patients admitted to the intensive care unit (ICU). Additionally, the study will assess the clinical impact, usability, and user satisfaction of ETPAAS.

The main questions it aims to answer are:

* Does ETPAAS reduce the duration of endotracheal tube malposition? * What are healthcare workers' perspectives on the usability and satisfaction of ETPAAS?

Participants will receive standard care, with or without ETPAAS, in the intensive care unit.

Researchers will evaluate the duration of endotracheal tube malposition. Healthcare workers will complete a questionnaire assessing the usability and satisfaction of ETPAAS.

Eligibility criteria

Qualifiers

Patients admitted to the intensive care unit

At least 18 years old

Disqualifiers

Patients disagree to participate in the study

Trial design

Treatments tested in this trial

  • "Endotracheal Tube Position Anomaly Alerting System"

Treatment groups

200 Participants
are divided into 2 treatment groups

Locations

1
Kaohsiung Medical University Chung-Ho Memorial Hospital807, Kaohsiung City Taiwan

Sponsors and collaborators

Kaohsiung Medical University Chung-Ho Memorial Hospital

Lead sponsor